The Bilophila Problem
Cardiovascular disease has a distinctive feature in its microbiome signature that makes oral iron supplementation uniquely harmful: Bilophila wadsworthia. This sulfite-reducing organism is obligately dependent on heme as an electron acceptor and thrives in iron-rich, sulfate-rich environments. It is consistently enriched in ACVD and heart failure microbiomes.
When oral iron reaches the colon unabsorbed:
- Bilophila wadsworthia uses it directly for sulfite reduction
- This generates hydrogen sulfide (H₂S) — a vascular toxin that damages endothelial nitric oxide (NO) signaling
- Reduced NO → impaired vasodilation → elevated blood pressure → increased vascular resistance
- H₂S also directly damages gut barrier → increased systemic endotoxemia
The TMAO-Iron Connection
The TMAO pathway is the most well-characterized gut-microbiome-CVD mechanism. Iron has a specific amplifying effect on TMAO production:
- Iron-replete Enterobacteriaceae and oral pathobionts (Streptococcus, Odoribacter) enriched in CVD dysbiosis upregulate TMA lyase expression
- TMA (trimethylamine) is produced from dietary choline, carnitine, and betaine → TMAO in the liver
- TMAO promotes cholesterol accumulation in macrophages → foam cells → atherosclerotic plaque
- More luminal iron → more TMA lyase activity → more TMAO → accelerated atherosclerosis
IV Iron Is Not Oral Iron
The clinical evidence for iron supplementation in heart failure (FAIR-HF, CONFIRM-HF, AFFIRM-AHF) uses intravenous iron — specifically ferric carboxymaltose. IV iron bypasses the gut entirely, correcting systemic iron deficiency without feeding colonic pathobionts. This evidence cannot be extrapolated to oral iron supplementation, which follows an entirely different (and harmful) pathway in CVD dysbiosis.
Practitioners should reserve oral iron for patients where IV administration is not feasible, and should confirm true iron deficiency (sTfR elevation, normal or low hepcidin, low ferritin) before supplementing in any form.
The Atherosclerotic Plaque Fenton Mechanism
Iron within atherosclerotic plaques participates in Fenton chemistry — Fe²⁺ + H₂O₂ → Fe³⁺ + OH⁻ + •OH (hydroxyl radical). Hydroxyl radical:
- Oxidizes LDL → oxLDL (the primary macrophage foam cell signal)
- Damages plaque collagen → plaque instability → rupture risk
- Promotes endothelial apoptosis → plaque erosion
Systemic iron loading from oral supplementation increases available iron at the plaque site, accelerating all three processes.